It contributes to tissue inflammation in immune-mediated inflammatory diseases, including rheumatoid arthritis, Crohn’s disease, and ulcerative colitis [4]. Adalimumab is one of the TNF inhibitors. The gene discussed is TNF; the disease is ulcerative colitis.